The brain is enriched in polyunsaturated fatty acids (PUFAs), particularly docosahexaenoic acid (DHA) and arachidonic acid (ARA), PUFAs of the omega-3 and omega-6 series, respectively. Maternal fish intake during pregnancy is positively associated with beneficial effects on child neurodevelopment, and low omega-3 PUFA intakes are associated with increased risk of preterm and early birth. Long-chain omega-3 PUFAs are important across all stages of neurodevelopment, including neurogenesis, cell migration and maturation, synaptogenesis, and synaptic pruning, but the essential role of long-chain omega-6 PUFAs must also be appreciated. Foetal demand for DHA and ARA is high, especially in the last trimester, the period of maximal brain growth, and where more than 90% of foetal fat deposition occurs. Consequently, preterm infants are at risk of low levels of DHA and ARA intake, putting them at risk of a long-chain PUFA gap of prematurity.
This webinar will present a summary of the evidence and highlights from recent studies for each of these topics. Overall, this webinar will highlight many of the latest studies in the area and provide new perspectives to viewers with some existing knowledge, but it is also suitable for those who are new to the topic.
What will I gain from this webinar?

Dr Simon Dyall leads the MSc Clinical Neuroscience programme at the University of Roehampton, and is Honorary Visiting Research Fellow in the Neuroscience, Surgery and Trauma Centre, Queen Mary University of London. He is Chair of the Scientific Advisory Board of the U.K. Association of Milk Banking and in addition to twice being elected to the Board of Directors of the International Society for the Study of Fatty Acids and Lipids, is on the Scientific Advisory Boards of the charities, Think Through Nutrition, and the Food For the Brain Foundation, and is on the Editorial Board of the journal, Lipids in Health and Disease. His research sits at the interface of neuroscience, nutrition, neurobiology and psychology (Nutritional Neuroscience), where his lab utilises both pre-clinical and clinical approaches to explore the role of bioactive lipids in brain health and disease across the lifespan.
